Panama vs Saudi Arabia: The number of people with susceptibility test result for rifampicin
Panama
497
in 2021
Saudi Arabia
591
in 2021
Panama rank
79th
Saudi Arabia rank
77th
The number of people with susceptibility test result for rifampicin over time
- Panama
- Saudi Arabia
How they compare
Saudi Arabia currently reports 591 against 497 in Panama, a difference of 94.
That makes Saudi Arabia's figure about 1.2 times Panama's.
Across all 5 years both countries report, Saudi Arabia has been ahead every year.
Panama ranks 79th and Saudi Arabia ranks 77th of 155 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Panama | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 477 | 1,131 | 654 | Saudi Arabia |
| 2020s | 452.5 | 590.5 | 138 | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Panama or Saudi Arabia?
- Saudi Arabia, at 591 against 497 in Panama as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Panama and Saudi Arabia?
- 94, with Saudi Arabia ahead.
- How many years of comparable data are there for Panama and Saudi Arabia?
- 5 years are reported by both, from 2017 to 2021.
- How do Panama and Saudi Arabia rank globally for the number of people with susceptibility test result for rifampicin?
- Panama ranks 79th and Saudi Arabia ranks 77th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.